Enzymotec Investors Want Suits Over $70M IPO Combined
Shareholders suing Israeli biotechnology and health products company Enzymotec Ltd. for allegedly misrepresenting the company's potential profitability ahead of its estimated $70 million initial public offering last year asked a New...To view the full article, register now.
Already a subscriber? Click here to view full article